Skip to main content
Guidance

The Innovative Devices Access Pathway (IDAP)

The Innovative Devices Access Pathway (IDAP) pilot is designed to accelerate the development of innovative medical devices that meet an unmet clinical need in the NHS and support their integration into the UK market.

Updates to this page

From:
Medicines and Healthcare products Regulatory Agency
Published:
19 September 2023
Last updated:
30 April 2026
Show all updates

  1. A further extension has been granted to HistoSonics Inc: EDISON™ SYSTEM AND ACCESSORIES (30 October 2026).

  2. Updated attachment 'The IDAP Unmet Clinical Need Authorisation (UCNA)' to reflect updated expiry date for: HistoSonics Inc - EDISON™ SYSTEM AND ACCESSORIES Expiry date: 30 April 2026 – Extension issued

  3. Attachment added - The IDAP Unmet Clinical Need Authorisation (UCNA)

  4. Updated to add note that iDAP pilot phase and Patient and public engagement in iDAP is now closed.

  5. Updated to reflect that Lenus Health have exited the IDAP pilot programme.

  6. Added Data Protection and Privacy information to The Innovative Devices Access Pathway (IDAP) - pilot phase page

  7. Changed to add Avegen Ltd to paragraphs on MS app being developed

  8. Changed attachment to note MS app has been developed by King's College London instead of Developed by Avegen Ltd.

  9. The IDAP pilot phase, pilot application and patient and public involvement and engagement pages have all been updated following the selection of the eight successful applicants

  10. Updated to add that the IDAP Pilot is closed for applications.

  11. Applications for the Innovative Devices Access Programme (IDAP) pilot now closes 1 November 2023 and further technical advice for applying has been updated.

  12. Details on 'How to Apply' have been updated to state that the IDAP Pilot is now closed for applications.

  13. FAQs have been added throughout the IDAP guidance webpage.

  14. Added a section title 'IDAP governance and patient and public involvement' to the IDAP pilot phase webpage.

  15. First published.

Documents

The IDAP Unmet Clinical Need Authorisation (UCNA)

HTML

The Innovative Devices Access Pathway (IDAP) - pilot phase (now closed)

HTML

IDAP pilot application guidance (now closed)

HTML

Patient and public involvement and engagement in IDAP (now closed)

HTML

IDAP Data Protection and Privacy information

PDF, 84.2 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Innovative Devices Access Pathway (IDAP) pilot is an initiative to bring new technologies and solutions to the National Health Service (NHS) to help with medical needs that are not currently being met.

The aim of IDAP is to enable and improve patient access to innovative and transformative medical devices by providing an integrated and enhanced regulatory and access pathway to developers. The aim of the pilot is to test the main elements of the pathway and to provide informative learning and feedback that helps to build the future IDAP.

The eight successful applicants whose products have been selected for the pilot will receive support at key stages of their product development journey  from the IDAP partners.

Sign up for emails or print this page